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Defective apical extrusion signaling 
contributes to aggressive tumor hallmarks
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Sean J Mulvihill2, Vita M Golubovskaya3, Jody Rosenblatt1*
1Huntsman Cancer Institute, University of Utah, Salt Lake City, United States; 
2Department of Surgery, University of Utah, Salt Lake City, United States; 
3Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo,  
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Abstract When epithelia become too crowded, some cells are extruded that later die. To extrude, 
a cell produces the lipid, Sphingosine 1-Phosphate (S1P), which activates S1P2 receptors in neighboring 
cells that seamlessly squeeze the cell out of the epithelium. Here, we find that extrusion defects 
can contribute to carcinogenesis and tumor progression. Tumors or epithelia lacking S1P2 cannot 
extrude cells apically and instead form apoptotic-resistant masses, possess poor barrier function, 
and shift extrusion basally beneath the epithelium, providing a potential mechanism for cell 
invasion. Exogenous S1P2 expression is sufficient to rescue apical extrusion, cell death, and 
reduce orthotopic pancreatic tumors and their metastases. Focal Adhesion Kinase (FAK) inhibitor 
can bypass extrusion defects and could, therefore, target pancreatic, lung, and colon tumors 
that lack S1P2 without affecting wild-type tissue.
DOI: 10.7554/eLife.04069.001
Introduction
Epithelial cells must act collectively to provide a protective barrier for the organs they encase even 
though they continuously turn over through cell death and division. The link between cell division and 
death is critical: if the relative death rate is too high, barrier function diseases may result whereas 
if division outpaces cell death, epithelia could become neoplastic. We previously identified a process 
critical for promoting cell death when cells within epithelia become overcrowded termed epithelial 
extrusion (Rosenblatt et al., 2001; Eisenhoffer et al., 2012). The stretch-activated channel Piezo-1 
senses cell crowding and enables some cells to produce the bioactive sphingolipid, Sphingosine 
1-phosphate (S1P), which binds G-protein coupled receptors (S1P2) in neighboring cells to activate 
Rho-mediated assembly and contraction of an intercellular actomyosin ring (Gu et al., 2011). This 
contraction squeezes live cells apically out of the epithelial sheet while simultaneously closing the gap 
that might have resulted from the cell's exit, thus preserving epithelial barrier function. Because live 
extruded cells become stripped from the underlying matrix and its associated survival signaling, they 
later die by anoikis (Frisch and Francis, 1994).
Advanced tumors typically have increased survival signaling that overrides anoikis, suggesting that 
cells could survive following extrusion. In this case, the direction a cell extrudes can impact its later 
fate. Typically, epithelia extrude cells apically into the lumen of the tissue (Slattum et al., 2009), which 
would act to essentially eliminate tumor cells with upregulated survival signaling. However, some cells 
are extruded basally into the tissue encased by the epithelium (Slattum et al., 2009). If basally 
extruded cells survive following extrusion, they might be able to invade into the underlying tissue 
(Slattum and Rosenblatt, 2014). Interestingly, we have found that oncogenic mutations in either 
adenomatous polyposis coli or K-Ras misregulate apical extrusion and drive extrusion basally (Marshall 
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Here, we examined the long-term effects of disrupting the S1P-S1P2 epithelia extrusion-signaling 
pathway. We found that inhibition of S1P2 leads to large epithelial masses in both zebrafish epidermis 
and cultured epithelia and increased rates of basal extrusion. Moreover, disrupting extrusion by a variety 
of methods leads to chemotherapy resistance. Inhibition of Focal Adhesion Kinase (FAK), a key survival 
signal generated from cell-matrix adhesion, selectively promotes apoptosis in cells where extrusion is 
defective and eliminates epidermal cell masses formed in zebrafish S1P2 mutants without affecting epi-
thelial morphology and function. Pancreatic Ductal Adenocarcinomas (PDACs) have little to no S1P2, 
which could explain why these tumors are typically more invasive and chemo-resistant. HPAF II human 
pancreatic cancer cells cannot extrude apically and instead extrude basally, survive, and proliferate fol-
lowing extrusion. Ectopically expressing S1P2 in HPAF II cells rescues apical extrusion and apoptosis and 
reduces orthotopic mouse tumors and their metastases. Together, our results suggest that defective 
extrusion may be a new mechanism for how PDACs and other carcinomas lacking S1P2 initiate and 
invade. Furthermore, FAK inhibitors, which are currently in clinical trials for other tumors, may provide an 
effective therapeutic opportunity to treat pancreatic cancer without destroying nearby normal tissue.
Results
Disruption of extrusion signaling reduces epithelial apoptosis rates
To test if the S1P-S1P2-Rho signaling pathway that controls extrusion (Gu et al., 2011) was critical for 
preventing neoplastic growth over time, we knocked down S1P2 in Human Bronchial Epithelial (HBE) 
cells (Figure 1A) and grew them for up to 3 weeks after they formed an intact monolayer. S1P2-
depleted HBE epithelia, which are extrusion-deficient (Gu et al., 2011), accumulated into masses over 
three layers thick whereas control-knockdown monolayers retained a single layer (Figure 1B). Because 
cell extrusion typically promotes epithelial cell death (Eisenhoffer et al., 2012; Marinari et al., 
2012) and because S1P2 depletion did not affect the proliferation rate in a yellow tetrazolium MTT 
(3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) assay (Figure 1C), masses were likely to 
eLife digest Epithelial cells cover the surface of our bodies, line our lungs, stomach and 
intestines and serve as a protective layer around other organs. If too many epithelial cells die and 
are not replaced, this protective layer may erode and lead to organ damage. However, if too many 
new cells grow, tumors can form.
One process that helps to maintain the right number of epithelial cells is called extrusion. 
When too many epithelial cells are present, the resulting overcrowding triggers this process to 
squeeze excess cells out of the layer and away from the organ. Usually, these cells quickly die. 
However, if the pathway that regulates this process—which involves a receptor protein called 
S1P2—is disturbed, the cells may instead be pushed into the space between the epithelial layer and 
the organ. When this happens, the cells are more likely to survive and may then form a tumor that 
invades the organ.
Gu et al. interfered with extrusion by reducing the levels of the S1P2 receptor in layers of human 
epithelial cells grown in the laboratory. Fewer epithelial cells were squeezed out of these cell layers, 
making the layers up to three times as thick in places. Moreover, mutant zebrafish lacking the S1P2 
receptor also accumulated epithelial masses throughout their bodies.
Gu et al. found that disrupting the extrusion process made the cells resistant to chemotherapy, 
and that certain hard-to-treat human pancreatic, lung, and colon cancers had lower levels of the 
S1P2 receptors. Boosting the activity of S1P2 receptors helped to restore normal extrusion and 
reduced the size of pancreatic tumors in mice.
Gu et al. then focused on an enzyme called Focal Adhesion Kinase that helps cells to survive. Treating 
zebrafish with a drug to block the activity of this enzyme left normal fish unharmed. However, in 
mutant fish with malfunctioning extrusion pathways, the drug rescued the number of cells that died, 
reduced the size and number of masses, and cured their leaky skin barrier. If further studies confirm 
the results, the drug may offer a new, less toxic, treatment for certain cancers that do not respond 
to currently available treatments.
DOI: 10.7554/eLife.04069.002
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arise due to reduced apoptosis. Additionally, zebrafish larvae carrying a loss-of-function mutation in 
S1P2 (Miles apart [Mil]) cannot extrude apoptotic epidermal cells (Gu et al., 2011), and similarly accu-
mulated numerous epidermal cell aggregates throughout the body (18 ± 3.5 aggregates/fish, n = 22) 
by only 5 days post fertilization (dpf) (Figure 1D,E). By contrast, masses were undetectable in hetero-
zygote Mil or WT siblings of the same age (Figure 1D,E).
We next wondered if extrusion-deficient cells were also more resistant to cell death in response 
to apoptotic stimuli. While extrusion promotes apoptosis during normal homeostasis by extruding 
live cells that later die from loss of contact to matrix-derived survival signaling (Eisenhoffer et al., 
2012), treating epithelia with apoptotic stimuli causes cells to simultaneously die and extrude 
(Rosenblatt et al., 2001; Andrade and Rosenblatt, 2011). Because extrusion normally drives cell 
death, could it also help promote apoptosis in response to apoptotic stimuli by eliminating compet-
ing survival signaling associated with the underlying matrix? We find that disrupting extrusion signal-
ing also disrupted apoptosis in response to a variety of apoptotic stimuli. HBE monolayers lacking 
S1P2 (Figure 2A) or treated with a selective S1P2 receptor antagonist, JTE-013 (Figure 2B) had 
greatly reduced rates of apoptosis in response to a strong apoptotic stimulus, UV-C, compared to 
controls. Madin–Darby Canine Kidney (MDCK) monolayers treated with S1P2 antagonist were simi-
larly resistant to several common chemotherapy drugs that cause apoptosis (Figure 2B,C).
Figure 1. Loss of S1P2 and extrusion leads to accumulation of epithelial cell masses. (A) S1P2 immunoblot of HBE cells expressing control (left)  
or S1P2-specific shRNA (right) with α-tubulin as loading control. (B) Representative images of HBE cells (DNA only) expressing control (left) or S1P2-specific 
shRNA (right) grown for 3 weeks. Scale bar, 10 µm. (C) Proliferation assay indicates that S1P2-knockdown cells proliferate at the same rate as wild type 
controls cells. (D) Representative DIC micrographs of 5-dpf WT (top) and Mil (S1P2 mutant) (bottom) zebrafish larvae, where cartoon shows region where 
fish was imaged. Scale bars, 100 µm where red box indicates region imaged. (E) Quantification of epidermal clumps of 22 zebrafish larvae.
DOI: 10.7554/eLife.04069.003
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The reduced cell death rates in epithelia lacking S1P2 were due to disruption of extrusion rather 
than altered S1P signaling, since other inhibitors of extrusion, Rho kinase inhibitor (Y-27632), myosin II 
inhibitor (Blebbistatin), or Rac inhibitor (EHT1864) all decreased cell death rates to the extent that 
they inhibit extrusion (Figure 3A). In each case, the ratio of cell death to extrusion inhibition is ∼1:1 
(Figure 3C). Inhibition of apoptosis was not due to increasing levels of S1P, which can act as a pro-
survival signal, as S1P levels in apoptotic cells varied independently of extrusion inhibition (Figure 3B). 
Since freshly plated single MDCK cells are resistant to apoptotic stimuli, we tested if these same com-
pounds reduced apoptosis in similarly aged single MDCKs by treating with EGTA to disrupt cadherin-
dependent cell–cell contacts. Inhibitors that blocked apoptosis by blocking extrusion in an intact 
monolayer do not impact the apoptosis rates of single cells that are incapable of extrusion (Figure 3D). 
Similarly, UV-induced apoptosis was unaltered in single HBE cells lacking S1P2 when HBE monolayers 
where treated with EGTA (Figure 3D). Additionally, inhibiting S1P2 with JTE-013 in a cell line that 
cannot extrude but expresses this receptor (Clair et al., 2003; Pham et al., 2013), NIH 3T3 fibroblasts, 
does not affect the cell death rate in response to UV-C (Figure 3E). These data together suggest 
that increased cell survival is linked with the inability to extrude rather than to any intrinsic block of the 
apoptosis pathway.
Pancreatic cancer cells lack the S1P2 receptor and extrude basally 
rather than apically
Since disruption of S1P2 in epithelia results in reduced apoptosis and cellular masses both in vitro and 
in vivo, we wondered if this receptor might be deficient in carcinomas. Our analysis of published tumor 
microarray data found S1P2 mRNA to be significantly reduced in PDAC (Buchholz et al., 2005; Segara 
et al., 2005; Badea et al., 2008), and some lung and colon tumors (Bhattacharjee et al., 2001), 
compared to their corresponding normal tissues. To investigate if cancer cells lacking S1P2 also have 
extrusion and apoptosis defects, we analyzed a pancreatic adenocarcinoma cell line, HPAF II, that 
has reduced S1P2 levels (Figure 4A) and forms epithelial monolayers necessary for assaying extru-
sion. We used MDCK and HBE cells as controls, which are well characterized in several extrusion 
studies (Rosenblatt et al., 2001; Slattum et al., 2009; Gu et al., 2011), as the only immortalized 
normal pancreatic cells, HPDEs, cannot form a confluent monolayer (data not shown).
Our experiments show that the reduced S1P2 levels in HPAF II cells disrupted apical extrusion, 
leading to reduced apoptosis rates and enhanced basal extrusion. Similar to HBE monolayers lacking 
S1P2, HPAF II cells formed masses within a week of culture and displayed extrusion defects and 
reduced rates of UV-C-induce apoptosis (Figure 4A–D). While ∼50% of cells did not extrude, most of 
the remaining cells extruded in the opposite direction—basally, underneath the layer (Figure 4D,E) at 
Figure 2. Disruption of S1P2-extrusion signaling reduces apoptotic response. (A) Quantification of UV-induced apoptotic cells in HBE monolayers 
expressing control or S1P2-specific shRNA. (B) Quantification of UV-induced apoptosis of HBE monolayers in the presence or absence of the S1P2 
antagonist JTE-013. (C) Quantification of indicated chemotherapy-induced apoptotic MDCK cells in the presence or absence of JTE-013, where all error 
bars are STD (**p < 0.01, and ***p < 0.001).
DOI: 10.7554/eLife.04069.004
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rates similar to when MDCK monolayers are treated with S1P2 antagonist (Slattum et al., 2014). Basal 
extrusion of cells with upregulated survival signaling could potentially enable their invasion beneath 
the epithelium (Slattum and Rosenblatt, 2014). To investigate if basally extruded cells can survive 
following extrusion (Slattum and Rosenblatt, 2014), we analyzed extrusion from three-dimensional 
cysts, where the fate of basally extruded cells can be followed outside the cyst, rather than beneath 
a monolayer. MDCKs were used as controls, which, like HPAF II cells, form cysts with hollow apical 
lumens of 34 µm ± 5 µm in diameter when grown in Matrigel (Figure 5B). Approximately 30% of HPAF 
II cysts extrude cells basally that survive, compared to only ∼3% of MDCK cysts (Figure 5C,D). Live 
imaging confirmed that 28.6% of basally extruded cells remained alive throughout a 12-hr video, whereas 
those from MDCK cysts died during this time (Video 1, n = 5 videos of each). Importantly, S1P2-GFP 
expression is sufficient to rescue apical extrusion (Figure 5C), decrease the frequency of live cells that 
basally extrude (Figure 5D), and increase the percentage of cysts with dead cells in their lumens 
(Figure 5E). These data suggest that the S1P-S1P2 signaling required for extrusion is critical not only for 
promoting cell death but also for preventing basal extrusion, which could enable cells to invade.
Figure 3. Decreased apoptosis is due to blocked extrusion rather than S1P signaling. (A) Rates of MDCK cell death (left Y-axis, blue) correspond with cell 
extrusion rates (right Y-axis, yellow) in response to UV-C when treated with extrusion inhibitors. (B) Representative images of apoptotic cells with and without 
compounds that block extrusion. When extrusion occurs, the dying cell DNA lies above (out of plane from) the neighboring cells with a contracted 
actin ring but when it fails, it lies in the same plane as surrounding cells with an uncontracted actin ring. Only the S1P2 antagonist JTE013 causes 
significant S1P accumulation in the dying cell (second column), whereas blocking extrusion with the other compounds does not impact S1P levels, 
where p values of each drug treatment compared to control are listed on each S1P panel as asterisks (n = 4). Bar = 10 µm. (C) Ratio of reduction of 
extrusion to reduction of apoptosis shows nearly a 1:1 correlation throughout, where p-values compared to S1P2 are not significant. (D) Compounds 
used to block extrusion do not affect apoptosis rates in single MDCK cells treated with EGTA in response to UV. (E) Quantification of UV-induced 
apoptotic NIH 3T3 cells in the presence of vehicle or JTE-013; All results are expressed as mean values ± STD of three separate experiments  
(*p < 0.01, **p < 0.005, ***p < 0.005, and ****p < 0.0001), and NS in graphs B, D, and E indicate that p values of a unpaired T-test are not significant.
DOI: 10.7554/eLife.04069.005
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Figure 4. Pancreatic cancer cell line HPAF II accumulates into masses and extrudes basally. (A) S1P2 immunoblot of HBE (left), HPAF II (middle), and 
MDCK (left) cells with α-tubulin as loading control. (B) Cell death rates in response to UV-C. (C) Quantification of cell extrusion events from three 
independent experiments; n = 300 apoptotic cells per cell line, error bars are STD where *<0.01 and ***<0.0001. (D) Representative confocal projection 
and XZ cross-section (from region in dashed line above) of HPAF II cells that grew into masses rather than monolayers. (E) Representative confocal 
projections of HPAF II (upper panel) and HBE (lower panel) cells undergoing apical (left) or basal (middle) extrusion, with XZ sections below. Basal 
extrusion was scored when an actin ring contracted above the dying cell (marked by DNA and caspase-3 staining) and the DNA of the dying cell 
lies in the same plane as the neighboring cells. Scale bars, 10 µm.
DOI: 10.7554/eLife.04069.006
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Inhibiting FAK rescues cell death rates in epithelia defective in 
extrusion
Because extrusion promotes cell death in response to apoptotic stimuli (Rosenblatt et al., 2001; 
Andrade and Rosenblatt, 2011) and during normal homeostasis (Eisenhoffer et al., 2012; 
Marinari et al., 2012), we hypothesized that it does so by eliminating the competing survival 
signaling associated with cell-matrix attachment. If so, increased cell survival when extrusion is blocked 
would derive from prolonged cell attachment to the underlying matrix. Since Focal Adhesion 
Kinase (FAK) is critical for matrix-dependent survival (Frisch et al., 1996), we investigated if FAK 
were increased in cells targeted for death when extrusion was blocked. Surprisingly, we found that 
control MDCK cells in early stages of extrusion have far higher levels of active FAK, by immu-
nostaining with a phospho-FAK antibody, than surrounding live cells but that these levels decrease 
during later stages of extrusion (Figure 6A). This increase in pro-survival phospho-FAK in cells 
targeted to die mimics the increased levels of S1P, another pro-survival signal, in cells triggered to 
extrude and die that also decrease once cells extrude (Figure 3C and [Gu et al., 2011]). However, 
late-staged apoptotic cells (detected by piknotic DNA) still have high levels of active FAK when 
extrusion is blocked with S1P2 antagonist (Figure 6A). This paradoxical survival signaling increase 
in cells targeted to die may reflect cell-intrinsic compensatory signals to apoptotic signaling that 
eventually decrease as cells commit to apoptosis. The fact that these survival signals stay high 
when cell extrusion is blocked suggests that this increased survival signaling derives from inability 
to detach from matrix.
Figure 5. Exogenous expression of S1P2 rescues apical extrusion and cell death. (A) GFP immunoblot of HPAF II cells expressing S1P2 GFP.  
(B) Representative confocal projections of MDCK, HPAF II, and HPAF II-S1P2 cysts, where scale bar = 10 µm. (C) Percentages of MDCK, HPAF II GFP, and 
HPAF II S1P2 cysts with basal extrusion; n = 300 cysts per cell line. (D) Quantification of MDCK, HPAF II GFP, and HPAF II S1P2 cysts extruding live cells 
basally; n = 300 cysts per cell line. (E) Frequency of HPAF II GFP and HPAF II S1P2 cysts with dying cells inside the lumen; n = 300 cysts per cell line. All 
results are expressed as mean values ± STD of three separate experiments (**p < 0.01, and ***p < 0.001).
DOI: 10.7554/eLife.04069.007
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Because FAK activity remains high in cells 
where extrusion is blocked, we wondered if 
chemically blocking FAK activation would rescue 
the apoptosis rates of monolayers lacking functional 
S1P2 signaling. The specific FAK inhibitor PF 
573228 had no effect on untreated or UV-treated 
wild type monolayers (Figure 6B and [Slack-
Davis et al., 2007]), likely because cells not tar-
geted to extrude have quite low levels of active 
FAK (Figure 6A). However, this same FAK inhib-
itor rescued the cell death rates of monolayers 
where extrusion is blocked with S1P2 antagonist 
JTE013 or Rac inhibitor to those seen in wild 
type monolayers (Figure 6B). FAK inhibitor dra-
matically decreased phospho-FAK staining in 
cells where JTE013 blocks extrusion (Figure 6A). 
Over-expression of a dominant negative FAK 
isoform (FRNK) (Park et al., 2004) acted simi-
larly to FAK inhibitor (Figure 6C). Importantly, 
FAK inhibitor alone induced apoptosis of HPAF II 
cells in monolayers (Figure 6D) and even those 
basally extruding from HPAF II cysts (Figure 6E,F). 
Additionally, treatment with FAK inhibitor to cysts 
that had already accumulated live basally extruded cells was sufficient to nearly double apoptosis 
rates of basally extruded cells (from 15 ± 2% to 28 ± 3%) when added for only 2 hr.
FAK inhibitor eliminates S1P2 mutant zebrafish embryo epidermal 
masses and improves epidermal barrier function
Because inhibition of FAK appears to promote cell death of only extrusion-defective epithelial cells 
without affecting normal epithelia, we wondered if FAK inhibition could eliminate the epidermal 
masses of Mil zebrafish embryos as they formed without adversely impacting the animal. While FAK 
inhibitor had no visible effect on wild-type zebrafish at 5 dpf, it greatly decreased the number and size 
of epidermal cell masses in S1P2-mutant embryos of the same age (Figure 7A–C). While FAK inhibitor 
treatment sloughed off many of the epidermal cells, which could be found at the bottom of the dish, 
it also increased the apoptosis rate within the masses (Figure 7D). To test if FAK inhibitor could elimi-
nate epidermal masses after they form, we needed to inducibly knockdown S1P2 later in development, 
since Mil zebrafish mutants die due to heart defects around the time cell masses form (∼5 dpf; 
[Kupperman et al., 2000]). To do so, we used we photo-activated S1P2 morpholino at 24 hpf 
(see [Eisenhoffer et al., 2012] for characterization of this method) to knockdown S1P2 after heart 
development occurred. S1P2 morphants had 0.18-fold lower S1P2 protein levels (Figure 7E) and 
phenocopied the epidermal masses seen in Mil mutants (Figure 7F). Addition of FAK inhibitor to 
an S1P2 morphant at 5 dpf with epidermal masses caused the masses to slough off within 19 hr 
(Figure 7F, where n = 6 videos total). Remarkably, we found that while Mil embryos had poor 
epidermal barrier function, as assayed by Texas Red-DextranMW70 permeability, epidermal permeability 
was significantly reduced with FAK inhibitor (Figure 7A). These results suggest that FAK inhibitor alone 
may selectively target masses resulting from cells defective in extrusion and improve overall epithelial 
integrity without affecting the normal surrounding tissue.
Expression of S1P2 is sufficient to reduce orthotopic pancreatic tumors 
and their metastases
We have shown that disrupting S1P/S1P2 signaling inhibits epithelial cell death, causes masses, and 
promotes a potential mechanism for invasion—basal extrusion, which together could promote tumor 
formation and progression. Yet, it was not clear if this signaling pathway plays a role in malignancy. To 
test the role of S1P2 in tumorigenesis, we orthotopically transplanted HPAF II tumor cells expressing 
either GFP or S1P2-GFP into nude mice and found that S1P2 expression was sufficient to markedly 
reduce both tumor size and metastatic frequency (Figure 8A,B).
Video 1. An HPAF II cyst growing without apoptotic 
stimuli extrudes live cells basally. Note that some cells 
extrude and die while others survive and/or migrate away.
DOI: 10.7554/eLife.04069.008
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Figure 6. Inhibition of FAK activity specifically increases cell death in epithelial cells lacking S1P2. (A) Immunostaining of active phospho-FAK in 
early and late control extrusions and in a JTE-013 (S1P2 antagonist)-inhibited extrusion with late apoptotic cell or one with the FAK inhibitor 
PF573228, with averaged arbitrary fluorescence units and their p-values compared to early extruding cells in graph on right (n = 10 measurements 
each over three separate experiments). (B) Quantification of UV-induced MDCK apoptosis in the presence of control, JTE-013, or EHT1864 with or 
without treatment of the FAK inhibitor PF573228, where n = 3000. (C) Quantification of UV-induced apoptosis of MDCK cells and those expressing 
FRNK, where n = 3000. (D) Quantification of PF573228-induced apoptosis of HPAF II cells, where n = 3000. (E) Representative confocal projections 
of HPAF II cysts treated with control or PF573228. Scale bars = 10 µm. (F) Frequencies of HPAF II cysts with dying cells, live extruding cells, or neither, 
where n = 300. All quantification results are expressed as mean values ± STD of three separate experiments (*p < 0.05, **p < 0.01, ***p < 0.001, 
and ****p < 0.0001).
DOI: 10.7554/eLife.04069.009
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Human pancreatic ductal carcinomas lack S1P2 receptor
Further, we found that human pancreatic carcinomas have strikingly down-regulated S1P2 protein 
levels. Because tumors typically have different stromal to epithelial ratios compared to uninvolved 
pancreatic tissue that can confound microarray data, we immunostained fixed tissue slices for both 
S1P2 and cytokeratin to highlight epithelial cells so that we could compare S1P2 protein levels in the 
epithelia alone (Figure 9A). We found that S1P2 was significantly lower in pancreatic cancer (PDAC) 
cells compared to epithelial acini from uninvolved neck margins, from which PDACs may arise, or to 
pancreatic intraepithelial neoplasia (PanIN) precursor lesions (Figure 9A–C). Importantly, lower S1P2 
expression correlates with later tumor stages in both averaged (Figure 9B) and five patient-matched 
samples (Figure 9C). Loss of S1P2 expression in pancreatic cancers suggests that defective extrusion 
may contribute to human PDAC development.
Figure 7. FAK inhibitors eliminate epidermal cell masses in S1P2 zebrafish mutants and improve epidermal barrier function without affecting wild type 
zebrafish. (A) Representative confocal projections of 5-dpf WT (left) and Mil (S1P2 mutant) (right) zebrafish larvae treated with DMSO or FAK inhibitor 
PF573228, where high Texas-Red Dextran indicates poor permeability in Mil but is greatly reduced when barrier function is improved with FAK inhibitor 
treatment. Scale bar = 10 µm and red box indicates region of fish imaged. (B) 5 dpf Mil and wild type zebrafish treated with and without FAK inhibitor. 
Note that while FAK inhibitor-treated Mil have other developmental defects (heart and circulation), there are no obvious clumps as seen in the untreated 
fish. Scale bar = 100 µm and red box indicates region of fish imaged. Note FAK inhibitor does not affect WT zebrafish. (C) Quantification of epidermal 
masses in 5 dpf Mil zebrafish larvae with and without PF573228. (D) Quantification of apoptotic cells within epidermal masses with and without PF573228. 
For both, error bars are SD and p values are ***<0.0001. (E) Immunoblot showing knockdown of S1P2 by photo-activatable morpholinos. (F) Stills from a 
video where PF573228 was added to S1P2 morphant at 5 dpf, where red arrows show the edge of the epidermis over time, scale bar = 50 µm and red 
box indicates region of fish imaged. Time is hours:minutes following FAK inhibitor addition. Note: epidermal cells that are sloughed off become 
embedded in the agarose where fish is mounted.
DOI: 10.7554/eLife.04069.010
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Discussion
Our work presents a new paradigm for how an aggressive class of carcinomas may form and progress: 
failed extrusion (Figure 10). Normal epithelial cells produce S1P to trigger their extrusion and death 
once they become too crowded, simultaneously maintaining correct cell density and barrier function. 
Epithelia with defective S1P/S1P2 signaling cannot extrude apically. Extrusion-defective epithelia 
retain cells, which can result in resistance to homeostatic and chemotherapy-induced cell death and 
neoplastic masses. Further, a small number of cells also die without getting extruded, which can dis-
rupt barrier function. Aside from allowing access of inappropriate signals, poor epithelia barrier func-
tion could cause chronic inflammation—an important factor for tumor progression (Coussens and 
Werb, 2002). Additionally, defective apical extrusion signaling shifts extrusion basally, which could 
allow transformed cells to invade the underlying tissue (Slattum and Rosenblatt, 2014).
Basal extrusion may be a common hallmark of invasive tumor types. We have recently discovered 
that oncogenic KRasV12 expression degrades S1P through autophagy and causes cell masses and basal 
extrusion, similar to the extrusion defects observed when S1P2 is absent (Slattum et al., 2014). KRasV12 
is an important driver for the same cancers that lack S1P2—pancreatic, lung, and colon carcinomas—
and its expression alone reduces S1P2 (Slattum et al., 2014), which may explain why PanIN precursors 
have reduced S1P2 expression. Further, we have found that another oncogenic mutation, truncation of 
the adenomatous polyposis coli gene, also results in increased basal extrusion. While it is not clear 
what mechanisms drive tumor cell invasion, our work showing that exogenous expression of S1P2 can 
dramatically reduce basal extrusion rates and orthotopic tumor metastasis rates in tumor cells that lack 
this receptor suggests that S1P2-mediated extrusion may play an important role in metastatic cell 
invasion.
Because cancer cells lacking S1P2 have increased survival signaling due to an inability to detach 
from the matrix and its associated survival signaling through increased active FAK, we found that 
FAK inhibitor on its own could rescue cell death rates to those seen in wild type cells (Figure 7D). 
Surprisingly, FAK inhibitor could also reverse other extrusion defects, such as poor barrier function and 
survival of basally extruded cells, factors that together could contribute to tumor progression. The fact 
that adding FAK inhibitor can rescue these defects when added after they form further supports the 
notion that anoikis results from extrusion and also suggests that FAK inhibitors may be particularly 
good at treating pancreatic and other carcinomas defective in extrusion. Moreover, we expect a spe-
cific FAK inhibitor to not cause the common toxicities associated with standard chemotherapies, as it 
does not affect normal epithelial tissue. Another FAK inhibitor, PF-00562271, reduces tumor growth, 
metastases, and ameliorates tumor microenvironment when used in an orthotopic mouse model for 
pancreatic cancer (Stokes et al., 2011), suggesting this drug could be promising for pancreatic cancer 
patients. However, it is important to note that PF-00562271 also inhibits a FAK-related kinase Pyk-2, 
which promotes non-specific cell death (Schultze and Fiedler, 2011). The phase I clinical trial for 
PF-00562271 showed that while this drug was tolerated fairly well, it did cause nausea, vomiting, 
and diarrhea (Infante et al., 2012), symptoms indicative of poor gut barrier function, likely due to 
Figure 8. Exogenous S1P2 expression reduces orthotopic pancreatic tumors and rates of metastasis in mice. 
(A) Representative images of HPAF II GFP and HPAF II S1P2 orthotopic xenograft tumors in nude mice. (B) Summary 
of tumor weights and metastatic frequency.
DOI: 10.7554/eLife.04069.011
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excessive non-specific apoptosis. Our results suggest that a newer more specific FAK inhibitor, such as 
VS-4718 (Shapiro et al., 2014), may provide a more targeted therapy for patients with pancreatic and 
lung carcinomas that have aberrant extrusion signaling without the common toxicities associated with 
older chemotherapies.
Based on our previous findings that extrusion drives normal epithelial cell turnover, we have found 
that disruption of extrusion may contribute to a class of cancers with poor prognosis. We find that 
cancer cells that lack the extrusion-signaling axis not only have reduced cell death rates but also have 
poor barrier function and a propensity to extrude cells basally, properties that could lead to higher 
invasion and metastatic rates. Therefore, aberrant extrusion signaling in pancreatic and lung carcino-
mas could not only contribute to tumor initiation but also progression. Importantly, specific inhibition 
of FAK, which does not disrupt normal epithelial tissue, is sufficient to reverse all of the effects of dis-
rupted extrusion and could provide a better, less toxic therapy for this aggressive class of tumors.
Materials and methods
Cell culture
MDCK II cells were cultured in Dulbecco's minimum essential medium (DMEM) high glucose with 5% 
FBS (all from HyClone, Logan, UT) and 100 μg/ml penicillin/streptomycin (Invitrogen, Grand Island, NY) 
at 5% CO2, 37°C. HBE cells were cultured in MEM supplemented with 10% FBS and l-glutamine in a 
flask coated with human fibronectin type I (BD, Franklin Lakes, New Jersey), bovine collagen I 
(Advanced BioMatrix, San Diego, CA), and BSA (Invitrogen). HPAF II cells were cultured in MEM 
(HyClone) supplemented with 10% FBS.
Figure 9. Human pancreatic tumors have reduced S1P2 expression. (A) H&E (top panel) and confocal fluorescence images (middle and bottom panel) 
of normal acinar cells from uninvolved neck margin, PanIN, and invasive cancer cells. Scale bars, 100 and 10 µm, respectively. (B) Quantification of 
S1P2 fluorescence intensity in acinar cells, PanIN, and invasive cancer cells from five individual patients. p values were calculated with a paired t test. 
(C) Changes of S1P2 fluorescence intensity from normal acinar cells to invasive cancer cells in each individual patient.
DOI: 10.7554/eLife.04069.012
Cell biology | Human biology and medicine
Gu et al. eLife 2015;4:e04069. DOI: 10.7554/eLife.04069 13 of 17
Research article
Culturing HPAF II and MDCK cells in Matrigel 
generated HPAF II and MDCK cysts, respectively. 
Briefly, a single cell suspension of HPAF II cells 
was resuspended in Growth Factor Reduced 
Matrigel (BD Biosciences) final concentration 4% 
and placed in eight well coverglass chambers 
(Nalge Nunc, Rochester, NY) coated with a thin 
polymerized layer of Matrigel. For live imaging, 
cells were placed on 24 well glass-bottom culture 
dishes (MatTeK Corporation, Ashland, MA). After 
20 min incubation at 37°C, cell-growth medium 
was added on top. Cysts were allowed to grow 
for the indicated duration and analyzed by time-
lapse imaging or fixed with 4% paraformaldehyde 
for immunostaining.
Generation of stable Doxycyclin-
inducible MDCK II cells over-
expressing dominant negative FAK
We first transfected MDCK II cells with neomycin-
resistant pTet-ON regulator plasmid, encoding 
rtTA protein (reverse tTA, tetracycline-controlled 
transactivator). The stable transfected MDCK II 
cells were selected by cultivation in media con-
taining 500 μg/ml G418. We then transfected 
Tet-ON MDCK II cells with FAK-CD-TRE-2-hyg plas-
mids (Golubovskaya et al., 2009) and selected for 
stably transfected cells with 0.1 mg/ml hygromycin. 
Expression of FAK-CD was induced with 2 µg/ml 
doxycycline for 4 days.
UV and drug treatment
MDCK II, HBE, or HPAF II cells grown to confluence 
on glass coverslips were exposed to 1200 μJ/cm2 
UV254 using a Spectrolinker (Spectroline, Westbury, 
NY) to induce apoptotic extrusion and incubated 
for 2 hr before fixation. Cells were treated with 
10 μM JTE-013 (Tocris Bioscience, United Kingdom), 
10 μM Y-27632, 10 μM Blebbistatin, 10 μM EHT 
1864 (all from Sigma–Aldrich, Saint Louis, MO), 
10 μM PF 573228 (Tocris Bioscience) or 1% DMSO 
as a control for 10 min before UV treatment. To 
induce apoptosis with chemotherapy drugs, cells 
were treated with 20 μg/ml Cisplatin, 1 μM Gemcitabine, or 20 μg/ml 5-Fluorouracil (all from Sigma–
Aldrich) for 24 hr.
Cell staining
Cells were fixed with 4% formaldehyde in PBS at 37°C for 20 min, permeabilized for 10 min 
with 0.5% Triton in PBS, blocked with AbDil (PBS with 0.1% Triton X-100 and 2% BSA) for 10 min, 
and incubated with primary antibody for 1 hr. Antibody concentrations used for immunostaining 
were: 1:200 rabbit anti-active caspase-3 (BD), 1:100 rabbit anti-phospho FAK (Tyr 397) (Cell 
Signaling, Danvers, Massachusetts), and 50 μg/ml anti-S1P mAb (LPath Inc., San Diego, CA). 
Alexa Fluor 488 goat anti–rabbit IgG and Alexa Fluor 488 goat anti–mouse IgG were used as 
secondary antibodies to detect active caspase-3 and S1P, respectively. Actin was detected 
with Alexa Fluor 568–phalloidin (Invitrogen). DNA was detected with 1 μg/ml Hoechst 33,342 
(Sigma–Aldrich).
Figure 10. Model for how extrusion can promote cell 
death and suppress tumor formation. Apical extrusion 
promotes death of grey-blue cell (top panel). Here, 
pro-survival signals phospho-FAK and S1P (which also 
promotes extrusion) increase in an early extruding cell 
but decrease once a cell is extruded and targeted to 
die (right, cell with piknotic nucleus). However, when 
apical extrusion is blocked due to lack of S1P2 receptor 
(bottom panel), epithelial cells do not die and can 
accumulate (left cell and those accumulating above) 
from increased matrix-derived survival signaling 
(arrows from matrix neighboring cells signaling to 
P-FAK). Additionally, cells can still basally extrude, 
which could potentially enable their invasion beneath 
the layer (right cell). Basally extruded cells may also 
have high P-FAK, since they are sensitive to FAK 
inhibitor when extruded into matrix in vitro, yet this 
point will be critical to test in vivo in disseminating 
tumors. Other cells may still die but not extrude 
(grey-blue cell with piknotic nucleus), leading to poor 
barrier function and inflammation, which could also 
promote tumor progression.
DOI: 10.7554/eLife.04069.013
Cell biology | Human biology and medicine
Gu et al. eLife 2015;4:e04069. DOI: 10.7554/eLife.04069 14 of 17
Research article
Human pancreatic sections
Pancreatic tissue sections (3 µm) were generated from formalin-fixed, paraffin-embedded tissue col-
lected from PDAC patient resections at the University of Utah Hospital. The sections were deparaffinised 
and rehydrated by incubating in citrus clearing solvent (CCS; Richard Allen Scientific, Kalamazoo, MI), 
100%, 95%, 80%, 70% ethanol, and PBS. For immunofluorescence, antigens were retrieved by heating 
the slides in boiling 10 mM sodium citrate for 20 min, then rinsed three times with PBS, blocked with 
5% BSA/0.5% Tween-20 in PBS for 4 hr, and incubated overnight with anti-S1P2 (Imgenex, San 
Diego, CA) and anti-pan cytokeratin (Sigma–Aldrich) at 4°C, rinsed five times with PBS, incubated in 
Alexa-488 anti-mouse antibody, 1 µg ml−1 Hoechst, and Alexa-568 anti-rabbit antibody for 2 hr, rinsed 
three times in PBS, and mounted in Prolong Gold (Invitrogen). Fluorescence micrographs of stained 
slides were obtained using a Leica DM 6000B microscope and captured using a Micromax charge- 
coupled device camera (Roper Scientific, Sarasota, Florida). IPlab Software was used to control the 
camera and to process images. Pixel intensity interested area was measured with ImageJ. The 
University of Utah Institutional Review Board approved the use of human tissue in this study. Tissue 
sections were obtained from excess clinical pathology tissue from patients, deidentified, resected for 
pancreatic adenocarcinoma at the University of Utah Huntsman Cancer Institute with appropriate 
informed consent for use of samples for research purposes (IRB_00010924).
Zebrafish treatment and staining
We sorted Mil zebrafish embryos from their WT homozygous and heterozygous siblings at 2 days post-
fertilization (dpf) by the presence or absence of tail blisters. We then treated half of Mil mutants and 
half of the wild type siblings with FAK inhibitor (10 μM PF 573228) for 3 days and added Texas Red-
DextranMW70 30 min before fixation. Embryos were then fixed in PBS with 4% formaldehyde and 0.1% 
Triton X-100 overnight, blocked with 2 mg/ml BSA for 2 hr, and stained for anti-E Cadherin (Gentex, 
Zeeland: MI) for 4 hr followed by incubation with Alexa Fluor 488 anti–rabbit IgG Ab. DNA was 
visualized using 1 μg/ml DAPI.
Zebrafish morpholino
The antisense morpholino oligonucleotides and photo-morpholino oligonucleotides were acquired 
from Gene Tools, LLC (Philomath, OR). For the photo-morpholino experiments, the translation blocking 
antisense morpholino (4 ng/embryo of each) was mixed at a 1:1 molar ratio with a 25 bp sense photo-
morpholino and injected into 1–2-cell-stage wild-type AB zebrafish embryos. At 28–32 hpf, embryos 
were exposed to 350 nm light for 20 s to release the caging sense morpholino, then treated with 10 μM 
PF 573228 (FAK inhibitor), and filmed by timelapse video microscopy on a spinning disc confocal.
Image and video acquisition
Confocal Imaging was performed in a Nikon Eclipse TE300 inverted microscope converted for spin-
ning disc confocal microscopy (Andor Technologies, United Kingdom) using a 40× Nikon Apo LWD 
lenses. Images were acquired with an electron-multiplied cooled charge-coupled device camera 
(DV887 1004X1002; Andor Technologies) driven by Andor IQ2 imaging software. All images were 
processed further using Photoshop and Illustrator (Adobe, San Jose, CA), and QuickTime Pro (Apple, 
San Jose, CA) software.
Live imaging of HPAF II cysts was taken with an OLYMPUS 1X71 inverted microscope using 
a 20× lens. The images were taken every 5 min for 12 hr. Temperature was controlled by a Weather 
station connected to the microscope.
For live imaging, FAK inhibitor treated S1P2 morpholino fish were anesthetized with 0.02% Tricaine 
in E3, mounted in 1% low melt agarose and imaged on a spinning disc confocal at 20×, capturing 
a z-series every 2 min (Eisenhoffer and Rosenblatt, in press) for 3–6 hr.
Quantification of apoptosis and cell extrusion
To quantify the frequency of apoptosis within a monolayer, we counted the number of active caspase-3 
positive cells still in contact with the monolayer per 1000 cells. We excluded round cells with strong 
caspase-3 staining that were not associated with monolayers, which were likely extruded well before 
experimental treatments could have impacted them.
To quantify extrusion, extruding cells were manually scored based on the presence of an actin ring 
compared to where apoptotic cell localized with respect to its neighboring cells. Apoptotic cells above 
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the plane of the monolayer with strong actin staining around and below them were defined as apically 
extruded cells. Apoptotic cells remaining in the monolayer and underneath an apical actin ring were 
considered basally extruded cells. Active caspase-3-positive cells that were not surrounded by a dis-
tinguishable actin ring were defined as non-extruded apoptotic cells.
Immunoblot analysis
Whole-cell extracts were prepared by resuspending cells in NP40 Cell Lysis Buffer (Invitrogen) plus 
protease inhibitor cocktail and PMSF (Roche, Switzerland). Proteins were resolved by SDS-PAGE 
using NuPage gels (Invitrogen), and transferred to polyvinylidene difluoride membrane (Thermo, 
Waltham, MA). Membranes were blocked with 5% dry milk and probed with anti-tubulin 1:1000 
(Sigma–Aldrich) and anti-GFP 1:10,000 (Clontech, Mountain View, CA) or anti S1P2 1:500 (Santa Cruz, 
Santa Cruz, CA) and identified using horseradish peroxidase conjugated secondary antibodies and 
enhanced chemiluminescense.
Molecular cloning
pLL5.0 is a lentiviral expression plasmid containing a U6 promoter to drive expression of the shRNA 
sequence and a 5′-long terminal repeat to drive the expression of GFP. Designing and cloning of S1P2-
specific shRNA were performed as previously described (Gu et al., 2011). The full length of human 
S1P2 was PCR amplified and ligated into the EcoRI/BamHI sites of pLL5.0.
Lentiviral production and transduction
Retroviral production and infections were as described (Gu et al., 2011). Infected HPAF II or HBE cells 
were sorted for GFP by using a BD FACSAria Cell Sorter.
Surgical orthotopic pancreatic cancer xenograft mouse model
Animals were handled according to protocols approved by the University of Utah Institutional Animal 
Care and Use Committee. Mice were anesthetized under isoflurane gas; the abdominal skin and muscle 
were incised just off the midline and directly above the pancreas to allow visualization of the pancreatic 
lobes; the pancreas was gently retracted and positioned to allow for direct injection of a 100 µl bolus 
of 1 × 106 HPAF II cells expressing GFP or S1P2 GFP using a 1 cc syringe with a 30 gauge needle; the 
pancreas was placed back within the abdominal cavity; and both the muscle and skin layers were closed. 
8 weeks later, mice were sacrificed and xenograft tumors were resected and weighed. Metastatic tumors 
within abdominal wall, liver, and mesentery were also examined and resected.
Quantifications
P-FAK was quantified using Nikon Elements as the ‘ROI Sum Intensity’ on ROI statistics using the same 
ROI size for each projection micrograph measured, subtracting background average fluorescence. 
Lumen sizes were also measured using Nikon Elements using ‘Radius size’ using the largest diameter 
in the ‘Annotations and Measurements’ analysis package. The statistical analysis was performed using 
an unpaired or paired t test. Values of p < 0.05 were considered significant.
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